drugset / Trial / NCT06904287

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

NCT06904287

Phase 3 Recruiting 100 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.

Timeline

Start
2025-12-16
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 2 g Intravenous
Background Prochlorperazine Small molecule 10 mg Intravenous

Indications